GlassScriptPhysician profile
Julie C Eapen
NPI 1477821817
$1,443.43
in general payments reported to CMS, 2019-2025
13 companies · $409 in 2025
The $409 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.07 · 2022: $302 · 2023: $325 · 2024: $380 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $478.29 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Genzyme Corporation | $160.81 | 2022-2024 | |
| Biogen, INC. | $142.97 | 2022-2025 | Spinraza, Tecfidera |
| Pharming Healthcare, INC. | $120.84 | 2023-2025 | Ruconest |
| Ascendis Pharma Endocrinology INC | $120.60 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.82 | 2022-2025 | Eohilia |
| Sobi, INC | $80.67 | 2022-2023 | |
| Cranial Technologies, INC | $64.93 | 2022-2025 | Doc Band |
| Philips North America LLC | $42.54 | 2019-2024 | (Ak6) Vest Therapy |
| Azurity Pharmaceuticals, INC. | $40.99 | 2023-2024 | Triptodur, Triptodur |
| Grifols USA, LLC | $38.08 | 2023 | Xembify |
| Soleno Therapeutics, INC. | $34.36 | 2025 | Vykat Xr |
| Regeneron Healthcare Solutions, INC. | $30.53 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Eapen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.